Sort
17,828 grants matching “crispr”
Intratumoral Heterogeneity and Plasticity in Basal-Like Breast Cancers
$40,410Cherise Ryan Glodowski · Univ Of North Carolina Chapel Hill · F31 · FY2022 · CA
Characterizing the Role of NOTCH2 in Neuroendocrine Tumors
$40,407Brendon Robert Herring · University Of Alabama At Birmingham · F31 · FY2022 · CA
Molecular mechanisms of the mitochondrial calcium uniporter
$40,390Ming-Feng Tsai · University Of Colorado Denver · R01 · FY2019 · GM
Extracellular Matrix Remodeling and the Control of Invasive Lobular Carcinoma Progression
$40,384Adam Wallace Olson · University Of Michigan At Ann Arbor · F31 · FY2023 · CA
Metabolic alterations contributing to enzalutamide resistance in prostate cancer
$40,370Eliot Blatt · Ut Southwestern Medical Center · F31 · FY2021 · CA
Investigating functional interactions with KRAS G12C inhibition
$40,316Kevin Lou · University Of California, San Francisco · F30 · FY2020 · CA
Characterization and engineering of a compact genome editor for adeno-associated virus delivery to correct mutations causing cystic fibrosis
$40,288Connor Andrew Tsuchida · University Of California Berkeley · F31 · FY2021 · HL
Molecular mechanisms of bacterial immune signaling through DNA damage
$40,287Chelsea Lee Blankenchip · University Of California, San Diego · F31 · FY2023 · GM
Defining the effects of noncoding genetic variation on human regulatory element activity
$40,286Kari Strouse · Duke University · F31 · FY2023 · HG
Dissecting the role of Erk signaling dynamics in positioning and coordinating germ layer fates
$40,255Naomi Jessie Baxter · University Of California Santa Barbara · F31 · FY2023 · HD
Targeted Chemical-Genetic Screen Platform for Identifying Novel AML Therapeutics
$40,252Kevin Jeng-Yen Lin · University Of Minnesota · F30 · FY2023 · CA
Defining the Regulatory Function of SOX2 in Squamous Cell Carcinoma
$40,223Reilly Falter · Utah State Higher Education System--University Of Utah · F31 · FY2025 · CA
Multimodal Single-molecule Analysis of DNA Interrogation by Cas9 and Cas12a: Examining the relationship between mismatches, DNA supercoiling, and conformational dynamics
$40,168Kevin Aris · Stanford University · F31 · FY2023 · GM
Defining Novel Roles of Ubiquitin Accumulation During the Mammalian Oxidative Stress Response
$40,144Austin O. Maduka · Duke University · F30 · FY2023 · ES
Dissecting the Role of Radiation in Regulation of MHC-I and Neoantigen Presentation
$40,139Chang Su · Duke University · F30 · FY2023 · CA
Developing optogenetic and chemogenetic approaches to control RNA metabolism in live cells
$40,134Bin Wu · Johns Hopkins University · R01 · FY2023 · GM
An All Optical Platform for Modeling and Monitoring Early Neurodegeneration in Human Neural Circuits
$40,104Nikki Tjahjono · University Of California At Davis · F31 · FY2023 · NS
Alternative splicing regulation of CLTC in the heart
$40,064Gabrielle Marie Gentile · Univ Of North Carolina Chapel Hill · F31 · FY2024 · HL
Harnessing the RNA-Cleaving Properties of CRISPR-Cas13a for Applications to HIV Detection and Latency
$40,061Parinaz Fozouni · University Of California, San Francisco · F30 · FY2019 · AI
Characterization of Altered Fatty Acid Trafficking in Triple-Negative Breast Cancer
$40,061Jeremy Williams · University Of California, San Francisco · F31 · FY2019 · CA
Reactivation of Gamma Globin Expression in β-Hemoglobinopathies
$40,054Ginette Theresa Balbin-Cuesta · University Of Michigan At Ann Arbor · F31 · FY2023 · HL
Control of Telomere Homeostasis by Nucleotide Metabolism in Hematopoiesis
$40,041William Mannherz · Harvard Medical School · F30 · FY2023 · DK
Mechanisms of meiotic and mitotic recombination
$40,005Jeff Joseph Sekelsky · Univ Of North Carolina Chapel Hill · R35 · FY2022 · GM
Molecular mechanisms of the ADPRHL2-mediated pediatric neurodegenerative disease
$39,970Shereen G. Ghosh · University Of California, San Diego · F31 · FY2020 · HD
Investigating the Impact of ABL Kinase Signaling on Epigenetic Reprogramming in Metastatic Triple Negative Breast Cancer
$39,948Ashley Colemon · Duke University · F31 · FY2023 · CA